XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses:        
Research and development $ 11,237,186 $ 1,887,367 $ 21,068,923 $ 6,233,214
General and administrative 5,946,396 1,820,043 18,846,299 4,311,902
Total operating expenses 17,183,582 3,707,410 39,915,222 10,545,116
Loss from operations (17,183,582) (3,707,410) (39,915,222) (10,545,116)
Other (expenses) income:        
Interest/investment income, net 363,300 37,916 1,174,957 66,965
Realized gain (loss) on short-term investments (86,171) (244,972)
Unrealized gain on short-term investments 3,946 290,973
Total other (expenses) income 281,075 37,916 1,220,958 66,965
Net loss $ (16,902,507) $ (3,669,494) $ (38,694,264) $ (10,478,151)
Loss per common share – basic and diluted (in Dollars per share) $ (1.05) $ (0.38) $ (2.52) $ (1.23)
Weighted average number of common shares outstanding – basic and diluted (in Shares) 16,044,670 9,761,188 15,371,118 8,515,560